Leishmania donovani: Identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis

Vaccine

Volumn 24, Issue 15, 2006, Pages 2900-2909

  Garg, Ravendra ^a   Gupta, Shraddha K ^a   Tripathi, Parul ^b   Hajela, K ^d   Sundar, S ^c   Naik, S ^b   Dube, Anuradha ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c BANARAS HINDU UNIVERSITY   (India)

^d DEVI AHILYA UNIVERSITY   (India)

Author keywords

Cured hamsters; Cured VL patients; Prophylactic efficacy; Soluble Leishmania donovani promastigote (SLD); T cell stimulatory antigen; Visceral leishmaniasis (VL)

Indexed keywords

AMMONIUM SULFATE; GAMMA INTERFERON; NITRIC OXIDE; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; ENDEMIC DISEASE; FRACTIONATION; HAMSTER; LEISHMANIA DONOVANI; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROMASTIGOTE; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELLS, CULTURED; CHEMICAL FRACTIONATION; CHILD; CHILD, PRESCHOOL; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INTERFERON TYPE II; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPHOCYTES; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE;

EID: 33644928988     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.053     Document Type: Article

References (55)

1. R.D. Pearson, A.Q. Souza, and S.M.B. Jeronimo Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis G.L. Mandell J.E. Bennett R. Dolin Principles and practice of infectious diseases vol. V 2000 Churchill Livingstone Philadelphia 2831 2844
2. E. Handman Leishmaniasis: current status of vaccine development Clin Microbiol Rev 14 2 2001 229 243
3. S. Sundar Drug resistance in Indian visceral leishmaniasis Trop Med Int Health 6 2001 849 854
4. A.A. Kamil, Khalil EAG, A.M. Musa, F. Modabber, M.M. Mukhtar, and M.E. Ibrahim Alum-precipitated autoclaved L. major plus BCG, a candidate vaccine for visceral leishmaniasis: safety, skin delayed hypersensitivity response and dose finding in healthy volunteers Trans R Soc Trop Med Hyg 97 2003 365 368
5. E.A.G. Khalil, N.B. Ayed, A.M. Musa, M.E. Ibrahim, M.M. Mukhtar, and E.E. Zijlstra Dichotomy of protective cellular immune responses to human visceral leishmaniasis Clin Exp Immunol 140 2005 349 353
6. C.L. Jaffe, R. Shor, H. Trau, and J.H. Passwell Parasite antigens recognized by patients with cutaneous leishmaniasis Clin Exp Immunol 80 1990 77 82
7. P.M. Kaye, A.J. Curry, and J.M. Blackwell Differential production of Th-1 and Th-2 derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine visceral leishmaniasis J Immunol 146 1991 2763 2770
8. D.M. Russo, E.M. Jardim, E.M. Carvelho, P.R. Sieath, R.J. Armitage, and R.W. Olafson Mapping human T cell epitopes in Leishmania gp63 identification of cross reactive and species specific epitopes J Immunol 50 1993 932 939
9. P.C. Melby, V.V. Tryon, B. Chandrasekar, and G.L. Freeman Cloning of syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis Infect Immun 66 1998 2135 2142
10. R. Garg, J.K. Srivastava, A. Pal, S. Naik, and A. Dube Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis Vaccine 23 2005 1189 1196
11. P.C. Melby, B. Chandrasekar, W. Zhao, and J.E. Coe The Hamster as a model of human visceral Leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response J Immunol 166 2001 1912 1920
12. R. Garg, S.K. Gupta, P. Tripathi, S. Naik, S. Sundar, and A. Dube Immunostimulatory cellular responses of cured Leishmania infected patients and hamsters against the integral membrane proteins and non membranous soluble proteins of recent clinical isolate of Leishmania donovani Clin Exp Immunol 140 2005 149 156
13. A. Dube, P. Sharma, J.K. Srivastava, A. Misra, S. Naik, and J.C. Katiyar Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG Parasitology 116 1998 219 221
14. P. Scott, E. Pearce, P. Natovitz, and A. Sher Vaccination against cutaneous leishmaniasis in a murine model I. Introduction of protective immunity with a soluble extract of promastigotes J Immunol 139 1987 221 227
15. A. Choudhury, P.Y. Guru, R.P. Saxena, A. Tandon, and K.C. Saxena Enzyme linked immunosorbant assay in diagnosis of kala-azar in Bhadohi (Varanasi) India Trans R Soc Trop Med Hyg 84 1990 363 367
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randal Protein measurement with folin-phenol reagent J Biol Chem 193 1951 265 275
17. E. Harlow, and D. Lane Antibodies: a laboratory manual 1988 Cold Spring Harbor Laboratory New York p. 298-9
18. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
19. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci USA 76 1979 4350 4354
20. C. Abou-Zeid, E. Filley, J. Steele, and G.A.W. Rook A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from western blot into antigen bearing particles J Immunol Methods 98 1987 5 10
21. W. Wray, T. Boulikas, V.P. Wray, and R. Hancock Silver staining or protein in polyacrylamide gels Anal Biochem 118 1981 197 203
22. J. Mehrotra, A. Mittal, M. Dindsa, and S. Sinha Fractionation of mycobecterial integral membrane proteins by continous elution SDS-PAGE revals the immunodominance of low molecular weight subunits for human T-cell Clin Exp Immunol 109 1997 446 450
23. A. Voller, D.E. Bidwell, and A. Bartlett The enzyme linked immunosorbent assay (ELISA): a guide with abstracts of microplate application 1979 Fileroline Press Guernsey Ci p. 1-125
24. A.H. Ding, C.F. Nathan, and D.J. Stuetr Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophage J Immunol 141 1988 2407 2412
25. A. Gaafar, A. Kharazmi, and A. Ismail Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections Clin Exp Immunol 100 1995 239 245
26. T. Laskay, H. Mariam, T.Y. Berhane, T.E. Fahniger, and R. Kiessling Immune reactivity to fractionesd Leishmania aethiopica antigens during active human infection J Clin Microbiol 29 1991 757 763
27. P.C. Melby, F.A. Neva, and D.L. Sacks Profile of human T cell response to leishmanial antigens anlysis by immunoblotting J Clin Invest 83 1989 1868 1875
28. A.C. White Jr., M. Castes, L. Gargcia, D. Rtujillo, and L. Zambrano Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection Am J Trop Med Hyg 462 1992 123 131
29. S.B.M. Jeronimo, E. Higgs, and T. Vedvick Identification of Leishmania chagasi antigens recognized by human lymphocytes J Infect Dis 172 1995 1055 1060
30. S.G. Reed, E.M. Carvalho, and C.H. Sherbert In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease J Clin Invest 85 1990 690 696
31. P. Probst, E. Stromberg, H.W. Ghalib, M. Mozel, R. Badaro, and S.G. Reed Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning J Immunol 166 2001 498 505
32. P.C. Melby Experimental leishmaniasis in humans: review Rev Infect Dis 13 1991 1009 1017
33. E. Mougneau, F. Altare, A.E. Wakil, S. Zheng, T. Coppola, and Z.E. Wang Expression cloning of a protective Leishmania antigen Science 268 1995 563 566
34. P.C. Melby, J. Yang, W. Zhao, L.E. Perez, and J. Cheng Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis Infect Immun 69 2001 4719 4725
35. E.P. De Souza, R.R. Bernardo, M. Palatnik, and C.B. Palatnik Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani Vaccine 19 2001 3104 3115
36. F. Afrin, R. Rajesh, K. Anam, M. Gopinath, S. Pal, and N. Ali Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice Infect Immun 70 2002 6697 6706
37. A.T. Jensen, A. Ismail, A. Gaafar, A.M. El Hassan, and T.G. Theander Humoral and cellular immune responses to glucose regulated protein 78. A novel Leishmania donovani antigen Trop Med Int Health 7 2002 471 476
38. W.R. Santos, I.A. Aguiar, E. Paraguai, E.P. De Souza, V.M. de Lima, and M. Palatnik Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine Vaccine 21 2003 4668 4676
39. P. Tripathi, S. Ray, S. Sunder, A. Dube, and S. Naik Identification of L. donovani antigens stimulating cellular immune responses in exposed immune individuals Clin Exp Immunol 143 2006 380 388
40. F. Bosque, N.G. Saravia, L. Valderrama, and G. Milon Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection Scand J Immunol 51 2000 533 541
41. S.R. Costa, A. D'Oliveira Jr., O. Bacellar, and E.M. Carvalho T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant leishmania antigens Mem Inst Oswaldo Cruz 94 1999 367 370
42. E.M. Carvalho, O. Bacellar, C. Brownell, T. Regis, R.L. Coffman, and S.G. Reed Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis J Immunol 152 1994 5949 5956
43. M. Belosevic, D.S. Finbloom, P.H. Van Der Meide, M.V. SLDyter, and C.A. Nacy Administration of monoclonal anti IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major J Immunol 143 1989 266 274
44. B.J. Holaday, M.D. Sadick, Z.E. Wang, S.L. Reiner, F.P. Heinzel, and T.G. Parslow Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines J Immunol 147 1991 1653 1658
45. F.Y. Liew, Y. Li, D. Moss, C. Parkinson, M.V. Rogers, and S. Moncada Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages Eur J Immunol 21 1991 3009 3014
46. J. MacMicking, Q.W. Xie, and C. Nathan Nitric oxide and macrophage function Annu Rev Immunol 15 1997 323 350
47. E.A.G. Khalil, A.M. El hassan, E.E. Zizlstra, M.M. Mukhtar, H.W. Ghalib, and B. Musa Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double blind, BCG-controlled trial in Sudan Lancet 356 2000 1565 1569
48. A. Misra, A. Dube, B. Srivastava, P. Sharma, J.K. Srivastava, and J.C. Katiyar Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG Vaccine 19 2001 3485 3492
49. Y. Nozaki, Y. Hasegawa, S. Ichiyama, I. Nakashima, and K. Shimokata Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages Infect Immun 65 1997 3644 3647
50. H.S. Warren, F.R. Vogel, and L.A. Chedid Current status of immunological adjuvants Annu Rev Immunol 4 1986 369 388
51. J.G. Howard, F.Y. Liew, C. Hale, and S. Nicklin Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes J Immunol 132 1984 450 455
52. R.X. Armijos, M.M. Weigel, H. Aviles, R. Maldonado, and J. Racines Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up J Infect Dis 177 1998 1352 1357
53. A.C. Ghose, J.P. Haldar, S.C. Pal, B.P. Mishra, and K.K. Mishra Serological investigations on Indian kala-azar Clin Exp Immunol 40 1980 318 326
54. P.A. Bretscher, O. Ogunremi, and J.N. Menon Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states Behring Inst Mitt 98 1997 153 159
55. K. Fragaki, I. Suffia, B. Ferrua, D. Rousseau, Y. Le Fichoux, and J. Kubar Immunization with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters Vaccine 19 2001 1701 1709